Solid Tumors Harboring Met Amplification clinical trials

Explore recruiting solid tumors harboring met amplification clinical trials.

Recruiting solid tumors harboring met amplification studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Solid Tumors Harboring Met Amplification trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of APL-101 in Subjects with Non-Small Cell Lung Cancer with c-Met Exon14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

France, Italy, Spain, Hungary

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Solid Tumors Harboring Met Amplification trials by city

Solid Tumors Harboring Met Amplification in Toronto Solid Tumors Harboring Met Amplification in Vancouver Solid Tumors Harboring Met Amplification in Montreal Solid Tumors Harboring Met Amplification in Calgary Solid Tumors Harboring Met Amplification in Edmonton Solid Tumors Harboring Met Amplification in Ottawa Solid Tumors Harboring Met Amplification in Winnipeg Solid Tumors Harboring Met Amplification in Quebec City Solid Tumors Harboring Met Amplification in Hamilton Solid Tumors Harboring Met Amplification in Kitchener Solid Tumors Harboring Met Amplification in London Solid Tumors Harboring Met Amplification in Halifax Solid Tumors Harboring Met Amplification in New York Solid Tumors Harboring Met Amplification in Los Angeles Solid Tumors Harboring Met Amplification in Chicago Solid Tumors Harboring Met Amplification in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease